title: APOE and neuroenergetics: an emerging paradigm in Alzheimer's disease.
abstract: APOE is the major known genetic risk factor for late-onset Alzheimer's disease. Though relationships between APOE-encoded apolipoprotein E and β-amyloid are increasingly well described, mounting evidence supports wide-ranging effects of APOE on the brain. Specifically, APOE appears to affect brain network activity and closely related neuroenergetic functions that might be involved in vulnerability to neurodegenerative pathophysiology. These effects highlight the salience of further investigation into the diverse influences of APOE. Therefore, this article reviews the interplay between APOE and neuroenergetics and proposes areas for further investigation. This research might lead to the identification of novel therapeutic targets for the treatment and/or prevention of Alzheimer's disease.
authors.affiliation: Department of Biochemistry, Midwestern University, Glendale, AZ, USA.
authors.forename: Andrew B
authors.initials: AB
authors.lastname: Wolf
authors.forename: Richard J
authors.initials: RJ
authors.lastname: Caselli
authors.forename: Eric M
authors.initials: EM
authors.lastname: Reiman
authors.forename: Jon
authors.initials: J
authors.lastname: Valla
mesh_terms: D000544:Alzheimer Disease / Q000503:physiopathology*; D001057:Apolipoproteins E / Q000378:metabolism*; D001921:Brain / Q000503:physiopathology*; D004734:Energy Metabolism; D006801:Humans; D008959:Models, Neurological
chemical_list: D001057:Apolipoproteins E